* Encompass Health Corp EHC.N EHC is expected to show a
rise
in quarterly revenue when it reports results on April 24 for
the period ending March 31 2024
* The Birmingham Alabama-based company is expected to
report a
9.7% increase in revenue to $1.273 billion from $1.16 billion a
year ago, according to the mean estimate from 10 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Encompass Health Corp is
for
earnings of 94 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Encompass
Health
Corp is $89.00, above its last closing price of $80.33.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.82 0.82 0.95 Beat 16.4
Sep. 30 2023 0.78 0.77 0.86 Beat 11.8
Jun. 30 2023 0.75 0.75 0.95 Beat 27.5
Mar. 31 2023 0.70 0.70 0.88 Beat 25.1
Dec. 0.83 0.83 0.88 Beat 5.8
31 2022
Sep. 30 2022 0.65 0.64 0.67 Beat 5
Jun. 30 2022 0.92 0.97 0.89 Missed -8
Mar. 31 2022 0.90 0.92 0.97 Beat 5.7
This summary was machine generated April 22 at 21:51 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)